A detailed history of Nordea Investment Management Ab transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nordea Investment Management Ab holds 5,772,583 shares of BMY stock, worth $307 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
5,772,583
Previous 7,692,398 24.96%
Holding current value
$307 Million
Previous $417 Million 42.53%
% of portfolio
0.29%
Previous 0.5%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $77.3 Million - $102 Million
-1,919,815 Reduced 24.96%
5,772,583 $240 Million
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $165 Million - $187 Million
-3,429,993 Reduced 30.84%
7,692,398 $417 Million
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $26.9 Million - $32.1 Million
-554,040 Reduced 4.74%
11,122,391 $571 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $22.3 Million - $24.9 Million
-384,399 Reduced 3.19%
11,676,431 $678 Million
Q2 2023

Jul 07, 2023

SELL
$63.71 - $70.74 $870,979 - $967,086
-13,671 Reduced 0.11%
12,060,830 $771 Million
Q1 2023

Apr 19, 2023

BUY
$65.71 - $74.53 $56.7 Million - $64.3 Million
863,174 Added 7.7%
12,074,501 $837 Million
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $34.7 Million - $41 Million
-506,199 Reduced 4.32%
11,211,327 $807 Million
Q3 2022

Oct 19, 2022

SELL
$0.13 - $76.84 $174,467 - $103 Million
-1,342,061 Reduced 10.28%
11,717,526 $840 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $170 Million - $187 Million
-2,342,256 Reduced 15.21%
13,059,587 $1 Billion
Q1 2022

Apr 11, 2022

SELL
$61.48 - $73.72 $168 Million - $201 Million
-2,728,612 Reduced 15.05%
15,401,843 $1.13 Billion
Q4 2021

Jan 20, 2022

BUY
$53.63 - $62.52 $168 Million - $195 Million
3,124,811 Added 20.82%
18,130,455 $1.14 Billion
Q3 2021

Nov 01, 2021

SELL
$59.17 - $69.31 $851 Million - $997 Million
-14,383,544 Reduced 48.94%
15,005,644 $907 Million
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $851 Million - $997 Million
14,384,712 Added 95.87%
29,389,188 $1.74 Billion
Q2 2021

Jul 16, 2021

BUY
$61.91 - $67.42 $89.2 Million - $97.2 Million
1,441,460 Added 10.63%
15,004,476 $1 Billion
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $19.7 Million - $22.2 Million
332,418 Added 2.51%
13,563,016 $854 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $682,602 - $773,513
-11,822 Reduced 0.09%
13,230,598 $821 Million
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $366 Million - $406 Million
-6,379,918 Reduced 32.51%
13,242,420 $793 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $530 Million - $619 Million
9,660,989 Added 96.98%
19,622,338 $1.15 Billion
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $6.77 Million - $9.83 Million
145,849 Added 1.49%
9,961,349 $551 Million
Q4 2019

Feb 11, 2020

SELL
$49.21 - $64.19 $96 Million - $125 Million
-1,949,835 Reduced 16.57%
9,815,500 $625 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $175 Million - $207 Million
4,080,024 Added 53.09%
11,765,335 $604 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $63.9 Million - $70.7 Million
1,432,464 Added 22.91%
7,685,311 $349 Million
Q1 2019

May 20, 2019

BUY
$45.12 - $53.8 $223 Million - $266 Million
4,950,748 Added 380.21%
6,252,847 $298 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $26.2 Million - $34 Million
537,649 Added 70.33%
1,302,099 $67.7 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $2.43 Million - $2.74 Million
44,019 Added 6.11%
764,450 $47.5 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $129,356 - $161,228
2,560 Added 0.36%
720,431 $39.9 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $4.15 Million - $4.78 Million
-69,251 Reduced 8.8%
717,871 $45.4 Million
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $2.06 Million - $2.24 Million
-34,326 Reduced 4.18%
787,122 $48.2 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $45.4 Million - $52.4 Million
821,448
821,448 $52.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.